logo

For the Inventor, By the Inventor

Noisy le Sec, France

Michel Delthil

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Sanofi-Aventis, Hoechst Marion Roussel. Active years: 1999-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Delthil. Retrieved from https://idiyas.com/inventor/michel-delthil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0


Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:

goldMedal3 out of 390 
 
Sanofi-Aventis
 patents
silverMedal2 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1999-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 8071788 - Method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide (2011-12-06),
2. 7652154 - Method and intermediates for the preparation of derivatives of N (1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide (2010-01-26),
3. 7429668 - Method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide (2008-09-30),
4. 6107488 - Phenylimidazolidine preparation process (2000-08-22),
5. 5969161 - 5-O-deaominyl 6-O-methyl erythronolide a derivatives, method for (1999-10-19),

Title: Michel Delthil: Innovator in Pharmaceutical Chemistry

Introduction

Michel Delthil is a notable inventor based in Noisy le Sec, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the synthesis of complex chemical compounds that have potential applications in medicine.

Latest Patents

Among his latest patents, Michel Delthil has developed a method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide. This invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide. His innovative approaches in this area demonstrate his expertise and commitment to advancing pharmaceutical research.

Career Highlights

Throughout his career, Michel has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Hoechst Marion Roussel. His experience in these organizations has allowed him to refine his skills and contribute to various projects that aim to improve healthcare solutions.

Collaborations

Michel Delthil has collaborated with several talented individuals in his field, including Philippe Boffelli and Luc Grondard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michel Delthil is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the synthesis of important chemical compounds. His contributions continue to impact the industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…